KR102762505B1 - 이식, 조직 재생, 장기형성 및 다중 조직 기능을 위한 부위로서의 지방-부속 림프 클러스터 - Google Patents

이식, 조직 재생, 장기형성 및 다중 조직 기능을 위한 부위로서의 지방-부속 림프 클러스터 Download PDF

Info

Publication number
KR102762505B1
KR102762505B1 KR1020197027026A KR20197027026A KR102762505B1 KR 102762505 B1 KR102762505 B1 KR 102762505B1 KR 1020197027026 A KR1020197027026 A KR 1020197027026A KR 20197027026 A KR20197027026 A KR 20197027026A KR 102762505 B1 KR102762505 B1 KR 102762505B1
Authority
KR
South Korea
Prior art keywords
delete delete
cells
tissue
ectopic
liver
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020197027026A
Other languages
English (en)
Korean (ko)
Other versions
KR20190116439A (ko
Inventor
에릭 라가세
Original Assignee
유니버시티 오브 피츠버그-오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 유니버시티 오브 피츠버그-오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 filed Critical 유니버시티 오브 피츠버그-오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션
Priority to KR1020257002956A priority Critical patent/KR20250020727A/ko
Publication of KR20190116439A publication Critical patent/KR20190116439A/ko
Application granted granted Critical
Publication of KR102762505B1 publication Critical patent/KR102762505B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/26—Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/33—Fibroblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
KR1020197027026A 2017-02-17 2018-02-20 이식, 조직 재생, 장기형성 및 다중 조직 기능을 위한 부위로서의 지방-부속 림프 클러스터 Active KR102762505B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020257002956A KR20250020727A (ko) 2017-02-17 2018-02-20 이식, 조직 재생, 장기형성 및 다중 조직 기능을 위한 부위로서의 지방-부속 림프 클러스터

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762460267P 2017-02-17 2017-02-17
US62/460,267 2017-02-17
US201762574119P 2017-10-18 2017-10-18
US62/574,119 2017-10-18
PCT/US2018/018684 WO2018152488A1 (en) 2017-02-17 2018-02-20 Fat-associated lymphoid clusters as sites for transplantation,tissue regeneration, organogenesis and function for multiple tissues

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020257002956A Division KR20250020727A (ko) 2017-02-17 2018-02-20 이식, 조직 재생, 장기형성 및 다중 조직 기능을 위한 부위로서의 지방-부속 림프 클러스터

Publications (2)

Publication Number Publication Date
KR20190116439A KR20190116439A (ko) 2019-10-14
KR102762505B1 true KR102762505B1 (ko) 2025-02-03

Family

ID=63170490

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020197027026A Active KR102762505B1 (ko) 2017-02-17 2018-02-20 이식, 조직 재생, 장기형성 및 다중 조직 기능을 위한 부위로서의 지방-부속 림프 클러스터
KR1020257002956A Pending KR20250020727A (ko) 2017-02-17 2018-02-20 이식, 조직 재생, 장기형성 및 다중 조직 기능을 위한 부위로서의 지방-부속 림프 클러스터

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020257002956A Pending KR20250020727A (ko) 2017-02-17 2018-02-20 이식, 조직 재생, 장기형성 및 다중 조직 기능을 위한 부위로서의 지방-부속 림프 클러스터

Country Status (12)

Country Link
US (2) US20190374583A1 (cg-RX-API-DMAC7.html)
EP (1) EP3582794B1 (cg-RX-API-DMAC7.html)
JP (3) JP2020508298A (cg-RX-API-DMAC7.html)
KR (2) KR102762505B1 (cg-RX-API-DMAC7.html)
CN (2) CN119097642A (cg-RX-API-DMAC7.html)
AU (1) AU2018221254B2 (cg-RX-API-DMAC7.html)
BR (1) BR112019016965A2 (cg-RX-API-DMAC7.html)
CA (1) CA3052295A1 (cg-RX-API-DMAC7.html)
ES (1) ES3070490T3 (cg-RX-API-DMAC7.html)
IL (2) IL268389B2 (cg-RX-API-DMAC7.html)
MX (2) MX2019009367A (cg-RX-API-DMAC7.html)
WO (1) WO2018152488A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4427813A3 (en) * 2019-04-11 2024-12-18 University of Pittsburgh- Of the Commonwealth System of Higher Education Minimally invasive cell transplant procedure to induce the development of in vivo organogenesis
WO2023076279A1 (en) * 2021-10-25 2023-05-04 Satellite Biosciences, Inc. Engineered tissue constructs for the treatment of crigler-najjar syndrome
CN116925997B (zh) * 2023-07-27 2024-04-02 湖北医药学院 左氧氟沙星在制备促进细胞增殖中的药物的用途

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014138486A1 (en) * 2013-03-06 2014-09-12 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Lymph node as a site for transplantation, organogenesis and function for multiple tissues and organs

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6312691B1 (en) 1996-01-26 2001-11-06 Jeffrey L. Browning Lymphotoxin-α/β complexes and anti-lympotoxin-β receptor antibodies as anti-tumor agents
ATE371018T1 (de) * 2001-06-22 2007-09-15 Stemcells Inc Le-zellen (liver engrafting cells), assays und verwendungen davon
US9125891B2 (en) * 2008-03-07 2015-09-08 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Lymph nodes as a site for regeneration
US11191785B2 (en) * 2008-03-07 2021-12-07 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Lymph node as a site for transplantation, organogenesis and function for multiple tissues and organs
AU2012352454A1 (en) * 2011-12-15 2014-07-17 The University Of Chicago Methods and compositions for cancer therapy using mutant light molecules with increased affinity to receptors

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014138486A1 (en) * 2013-03-06 2014-09-12 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Lymph node as a site for transplantation, organogenesis and function for multiple tissues and organs

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Reinhold Forster 외, "Orchestrating the organizers: lymphotoxin-ß receptor conducts fibroblastic reticular cell maturation", Immunity, 제38권, 제851-853면 (2013. 5. 23.)*
Robert L. Ferris 외, "Lymphatics, lymph nodes and the immune system: barriers and gateways for cancer spread", Clin. Exp. Metastasis, 제29권, 제729-736면 (2012년)*

Also Published As

Publication number Publication date
MX2019009367A (es) 2019-10-24
JP7784392B2 (ja) 2025-12-11
KR20250020727A (ko) 2025-02-11
MX2024005097A (es) 2024-05-15
IL268389A (en) 2019-09-26
EP3582794C0 (en) 2026-04-22
JP2025176014A (ja) 2025-12-03
JP2023061960A (ja) 2023-05-02
IL310219A (en) 2024-03-01
US20240091271A1 (en) 2024-03-21
IL310219B1 (en) 2026-03-01
CA3052295A1 (en) 2018-08-23
ES3070490T3 (en) 2026-06-16
WO2018152488A1 (en) 2018-08-23
US20190374583A1 (en) 2019-12-12
AU2018221254B2 (en) 2025-03-20
EP3582794B1 (en) 2026-04-22
BR112019016965A2 (pt) 2020-04-14
EP3582794A4 (en) 2020-12-09
CN119097642A (zh) 2024-12-10
CN110869032B (zh) 2024-08-23
KR20190116439A (ko) 2019-10-14
IL268389B2 (en) 2024-06-01
IL268389B1 (en) 2024-02-01
EP3582794A1 (en) 2019-12-25
CN110869032A (zh) 2020-03-06
AU2018221254A1 (en) 2019-08-15
IL310219B2 (en) 2026-07-01
JP2020508298A (ja) 2020-03-19

Similar Documents

Publication Publication Date Title
JP7784392B2 (ja) 移植、組織再生、器官形成及び複数の組織に対する機能のための部位としての脂肪関連リンパ球集積(fat-associated lymphoid cluster)
US9107910B2 (en) Isolated liver stem cells
JP2022031662A (ja) 膵機能障害の治療または予防方法
Mavila et al. Expansion of prominin‐1‐expressing cells in association with fibrosis of biliary atresia
US20210024885A1 (en) Methods and compositions for producing hepatocytes
US20250144146A1 (en) Lymph node as a site for transplantation, organogenesis and function for multiple tissues and organs
WO2014138486A1 (en) Lymph node as a site for transplantation, organogenesis and function for multiple tissues and organs
CN101356264A (zh) 分离的肝脏干细胞
HK40021179B (en) Fat-associated lymphoid clusters as sites for transplantation,tissue regeneration, organogenesis and function for multiple tissues
HK40021179A (en) Fat-associated lymphoid clusters as sites for transplantation,tissue regeneration, organogenesis and function for multiple tissues
US20250195579A1 (en) Lymph node as a site for transplantation, organogenesis and function for multiple tissues and organs
Tanimizu et al. Generation of functional liver tissue by establishing hepatobiliary connections ex vivo
Hallett The Human Hepatic Progenitor Cell as a Transplantable Source of Biliary Regeneration
BRPI0620049A2 (pt) células-tronco isoladas do fìgado

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20190916

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
AMND Amendment
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20210215

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20230411

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20231031

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20230411

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

X091 Application refused [patent]
PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20231031

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20230612

Comment text: Amendment to Specification, etc.

Patent event code: PX09012R01I

Patent event date: 20210215

Comment text: Amendment to Specification, etc.

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20240325

Patent event code: PE09021S01D

PX0701 Decision of registration after re-examination

Patent event date: 20241028

Comment text: Decision to Grant Registration

Patent event code: PX07013S01D

X701 Decision to grant (after re-examination)
A107 Divisional application of patent
GRNT Written decision to grant
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20250124

PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20250124

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20250124

End annual number: 3

Start annual number: 1

PG1601 Publication of registration